John de Koning

Partner at EQT Life Sciences (formerly LSP)

Amsterdam, North Holland

Investor

Invests in

Stages:

Sectors:

Health & Hospital Services

Health IT

Locations:

Amsterdam, Netherlands

Min Investment:
$11,000,000.00
Max Investment:
$65,000,000.00
Target Investment:
$25,000,000.00

Skills

Lifesciences

R&D

Biotechnology

Oncology

Molecular Biology

Immunology

Commercialization

Biopharmaceuticals

Technology Transfer

Biochemistry

Drug Discovery

Drug Development

Genomics

Clinical Trials

Genetics

Cell Culture

Hardware Diagnostics

Clinical Development

Cancer

Cell Biology

Education

Post Doctoral Fellow (Dutch Cancer Society)
University of California, San Francisco
PhD, Oncology at the Institute of Hematology
Erasmus Medical Center Rotterdam, The Netherlands
Msc
Utrecht University

Investments

Tubulis

Series B

Total Funding: $210M

VarmX

Series B

Total Funding: $83M

etherna immunotherapies

Series A

Total Funding: $66M

Visus Therapeutics

Debt Financing

Total Funding: $61M

Onward

Series Unknown

Total Funding: $51M

Merus

Series B

Total Funding: $150M

Work Experience

EQT Life Sciences

2022

Partner
2022
EQT Life Sciences (formerly LSP), is one of Europe’s largest and most experienced healthcare investment firms, targeting innovative life sciences and health care companies.

Visus Therapeutics, Inc.

2021